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Preeclampsia is often accompanied by hypoxia of the placenta and this condition induces apoptosis in tro-
phoblastic cells. The aim of this study was to characterize global changes of apoptosis-related proteins induced 
by hypoxia in trophoblastic cells so as to clarify the mechanism of hypoxia-induced apoptosis by using the 
PoweBlot, an antibody-based Western array. Human choriocarcinoma cell line JAR was cultured for 24 hours 
under aerobic and hypoxic conditions. Hypoxia induced apoptosis accompanied by increased expression of 
Bcl-x, Caspase-3 and -9, Hsp70, PTEN, and Bag-1. Bad, pan-JNK/SAPK-1, Bcl-2, Bid, and Caspase-8 showed de-
creased expression. Hypoxia-induced apoptosis was increased with the transfection of a bag-1 antisense oligonu-
cleotide. The bag-1 antisense oligonucleotide affected the expression of Bid, Bad, Bcl-2, JNK, and phosphorylated 
JNK, although expression of PTEN and Bcl-X did not change. Bag-1 may inhibit apoptosis by suppressing the 
expression of Bid and Bad. It may also enhance apoptosis by inhibiting the expression of Bcl-2 and by modulat-
ing phosphorylation of JNK. Both mitochondrial and stress-activated apoptosis pathways played important 
roles in the hypoxia induced cell death of trophoblastic cells. These findings will contribute to establish new ap-
proach to detect hypoxic stress of the placenta, which leads to preeclampsia and other hypoxia-related obstetrics 
complications.  
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1.  Introduction 
Hypoxia of the placenta is a cause of various 
complications of pregnancy. Clinical conditions such 
as preeclampsia, anemia, and smoking can be accom-
panied by villous hypoxia, characterized by dimin-
ished syncytial differentiation, syncytial knots, and 
prominent cytotrophoblasts [1]. Hypoxia is known to 
induce apoptosis in various cells, including tro-
phoblastic cells [2-4]. A higher degree of apoptosis is 
found in placentas from pregnancies complicated by 
intrauterine fetal growth retardation (IUGR) [5]. Simi-
larly, apoptosis is more prevalent in cytotrophoblasts 
from pregnancies complicated by preeclampsia com-
pared with similar specimens obtained from uncom-
plicated pregnancies [6]. Thus, apoptosis plays an 
important role in the development of various obstet-
rical complications.   
Apoptosis is a cascade of events that involves ac-
tivation of many genes and synthesis of various pro-
teins. The importance of several apoptotic pathways 
such as mitochondrial pathways and death receptor 
pathways has been reported [7,8]. However, apoptosis 
is a very complex process, and only a single pathway 
cannot explain the whole apoptotic network. The bal-
ance of the expression of positive and negative regu-
lators of apoptosis determines the apoptotic propen-
sity. Therefore, to understand the complicated net-
work of apoptotic pathways, detection of many genes 
as well as proteins is important. The cDNA microarray 
technique is one of the most powerful tools to eluci-
date the mechanism of this network. However, a poor 
correlation between mRNA and protein abundance 
has also been reported [9]. Furthermore, a single gene 
can encode for more than one mRNA species through 
differential splicing, and proteins can undergo as 
many as 200 posttranslational modifications. There-
fore, to understand the complicated network of hy-
poxia-induced apoptotic pathways, global detection of 
various proteins is essential. Recent advances in mo-
lecular biology and biochemistry have enabled analy-
sis of the expression profiles of numerous proteins at 
once.  
I n  t h i s  s t u d y ,  w e  l o o k e d  a t  h y p o x i a - i n d u c e d  
apoptosis and, by using the Western array technique, 
we monitored the expression of almost 40 apop-
tosis-related proteins after hypoxia in the choriocarci-
noma cell line JAR. Because of the limited availability 
of first, second, and early third trimester placental tis-
sues, the choriocarcinoma cell line JAR was used in-
stead. Furthermore, we also evaluated the changes of 
expression of apoptosis-related genes by using the 
RT-PCR and real-time RT-PCR techniques. 
Early prediction of preeclampsia is difficult. Sev-
eral maternal serum proteins such as PAPP-A, free  β
-HCG, placental growth factor, vascular endothelial 
growth factor and soluble fms-like tyrosine kinase-1 Int. J. Med. Sci. 2007, 4 
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are reported to be useful markers for the prediction of 
preeclampsia. However, it is still difficult to predict 
the occurrence of hypoxia-related complications pre-
cisely [10,11]. 
The aim of this study was to characterize global 
changes in the proteins related to apoptosis during 
hypoxia to clarify the mechanism of hypoxia-induced 
apoptosis, and to find out useful hypoxia-related 
markers of trophoblastic cells. 
2.  Materials and methods 
Cell line and cell cultures 
 The human choricarcinoma cell line JAR was 
obtained from American Type Culture Collection 
(Manassas, VA, USA). Cells were maintained in RPMI 
1640 medium supplemented with 20mM HEPES, 6 
mM glutamine, 100 IU of penicillin, 100 μg of strep-
tomycin, and 15% fetal calf serum in 25 cm2 or 75 cm2 
flasks at 37°C. 
Hypoxia treatment 
When JAR cells had reached 70-80% confluence, 
they were grown under aerobic or hypoxic conditions 
for 24 hours. The anaerobic chamber provided a hy-
poxic atmosphere, defined as 2% oxygen (5% CO2 and 
93% N2) that yielded a PO2 of < 15 mmHg. Standard 
aerobia was defined as 5% CO2 and 95% air (i.e., 20% 
oxygen). 
Antisense oligonucleotide treatment 
FITC-labeled morpholino oligomers were syn-
thesized at Gene Tools, LLC (Philomath, OR, USA) as 
described previously. Purity was >95% as determined 
by reverse-phase HPLC and matrix-assisted laser de-
sorption ionization time-of-flight mass spectroscopy. 
The base composition of the oligomer was as follows. 
The sequence of the Bag-1 morpholino antisense oli-
gomer (hereafter designated Bag-1 Morpho/AS) was 
5’- GCTGAGCCAGGCCCGCACTTGTTGA-3’. Mor-
pholino oligomer 
5’-CCTCTTACCTCAgTTACAATTTATA-3’ was used 
for the negative control.   
JAR cells were seeded on 25 cm2 flasks and after 
48 hours, when they had reached 70-80% confluence, 
the cells were transfected with Bag-1 Morpho/AS in 
serum-free conditions using a weakly basic delivery 
reagent, ethoxylated polyethylenimine (EPEI), as in-
structed by Gene Tools. Thus, 3.7 μl of Bag-1 Mor-
pho/AS stock solution (0.5 mM) and 3.7 μl of EPEI 
delivery reagent (200 μM) were mixed in sterile Milli 
Q water (125.9 μl) in a small tube. After immediate 
mixing with a vortex mixer and reaction at room tem-
perature for 20 minutes, 1.2 ml of serum-free medium 
(RPMI 1640 medium) was added, and mixed immedi-
ately to generate the complete delivery solution as 
instructed by Gene Tools. One milliliter of the Bag-1 
Morpho/AS/EPEI complex was added to each flask 
and incubated at 37°C for 3 hours. After transfection, 
the medium with transfection complex was removed, 
complete medium (1 ml) with 10% FBS was added, 
and incubation was continued. After 16 hours of in-
cubation, the cell pellets were collected for analysis. 
The intracellular location of the Bag-1 Morpho/AS 
was confirmed by fluorescent microscopy.   
Cell viability assay  
Cell viability assays were performed after 12 and 
24 hours of exposure of the cells to hypoxic or aerobic 
conditions. Briefly, cells were seeded on 6-well plates, 
and after 12- and 24-hour exposures to hypoxic or 
aerobic conditions, 200μl of 5mg/ml MTT (Sigma 
Chemical Co. St. Louis, MO, USA) was added to each 
well in a 6-well plate at 37°C until blue coloration 
started to appear in the cells. The medium was then 
aspirated and replaced with DMSO. The absorbance 
was read at 540nm in a microtiter plate reader.   
Quantitation of internucleosomal DNA fragmenta-
tion by ELISA 
 Internucleosomal DNA fragmentation as a re-
sult of apoptosis was measured with a Cell Death De-
tection ELISA (Boehringer Mannheim, Indianapolis, 
Ind. USA). Cells (1×104/well) were plated in 24-well 
plates. After exposure to hypoxia for 12-24 hours, the 
cells were collected by trypsinization, and the super-
natant of the cell lysate was assessed for DNA frag-
mentation according to the manufacturer’s protocol. 
The same procedures were also used under aerobic 
conditions for the cell line. From the absorbance at 405 
nm, the percent fragmentation in comparison with 
that in controls was calculated according to the for-
mula: DNA fragmentation (-fold of control) = absorb-
ance of drug-treated cells/absorbance of control cells. 
Becton Dickinson PowerBlot 
In this study, we analyzed forty proteins by us-
ing the PowerBlot (BD Bioscience Pharmingen, San 
Diego, CA, USA) system. We selected 40 apop-
tosis-related proteins to examine the mechanism of 
hypoxia-induced apoptosis. After the JAR cells were 
exposed to hypoxia or maintained under aerobic con-
ditions, protein extracts were analyzed as follows. 
First, 13×10 cm, 4-15% gradient SDS-polyacrylamide 
gels were used to separate the proteins, and 200 μg of 
protein was loaded on the gel (10 μg/lane). The gels 
were run for 1.5 hours at 150 volts and then trans-
ferred to Immobilon-P membranes for 2 hours at 200 
mAmp. The membranes were clamped with Western 
blotting manifolds capable of isolating 42 channels 
across the membrane. In each channel, a complex an-
tibody mixture was added and allowed to hybridize 
for 1 hour at 37°C. The blots were then removed from 
the manifold, washed, and hybridized for 30 minutes 
at 37°C with the secondary goat anti-mouse antibody 
conjugated to Alexa 680 fluorescent dye. The mem-
brane was washed, dried, and scanned at 700 nm us-
ing the Odyssey Infrared Imaging System. Results 
were expressed as fold change, a semi-quantitative 
value that represented the general trend of protein 
changes, either increasing or decreasing, for the ex-
perimental sample relative to the control. Changes 
were classified in the order of confidence, level 3 hav-
ing the highest confidence. Confidence levels were 
defined as: Level 3 – Changes greater than 2-fold from Int. J. Med. Sci. 2007, 4 
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good quality signals that also passed a visual inspec-
tion; Level 2 – Changes greater than 2-fold from good 
quality signals that did not pass a visual inspection; 
Level 1 – Changes greater than 2-fold from low quality 
signals; Level 0 – No significant protein changes. 
Forty apoptosis related proteins studied in this 
study are as follows: Akt (pS473), phospho-specific, 
Apaf-1, Bad, BAG-1, basic FGF, Bax,Bcl-2, Bcl-x, Bid, 
BRCA1, caspase-3, caspase-6, caspase-7, caspase-8, 
cox-2, cyclinD2, EGF receptor, EGF receptor (activated 
form), eNOS phosphor-specific, FADD, 
Fas/CD95/APO-1, GST-p, Hsp70, Hsp90, HspBP1, 
JNK (pT183/pY185) Phospho-Specific, JNK1, Ki67, 
JNK (pT183/pY185) phospho-specific, Nm23, PAI-1, 
pan-JNK/SAPK1, PARP, PCNA, PTEN, Rb, 
Smac/DIABLO, TRADD, XRCC4. 
Quantitation of phosphorylated JNK 1&2 by 
ELISA 
The phosphorylated JNK 1&2 protein level was 
measured with Phospho-JNK1&2 (pThr183/pTyr185) 
ELISA (SIGMA, Saint Louis, USA). After 12 hours and 
24 hours of exposure to hypoxia or normoxia, cells 
(1×106 cells/flask) were collected by trypsinisation. 
Cell lysates of hypoxia-treated cells and untreated 
control cells were assayed for phosphorylated JNK 
1&2 protein according to the manufacturer’s protocol. 
Briefly, cell lysates diluted >1:10 were incubated in 
96-well plates coated with an anti-JNK 1&2 antibody 
for 2 hours. Then an anti-phospho-JNK 1&2 
(pThr183/pTyr185) rabbit antibody was added, and in-
cubated for 1 hour. After washing the wells, an 
anti-rabbit IgG-HRP antibody was added, and incu-
bated for 30 minutes. Stabilized Chromogen (TMB) 
was added to each well, and from the absorbance at 
450 nm, the phosphorylated JNK 1&2 protein level in 
comparison with the control was calculated according 
to the formula: Changes in the level of phosphorylated 
J N K 1 & 2  ( - f o l d  o f  c o n t r o l )  =  a b s o r b a n c e  o f  h y -
poxia-treated cells/absorbance of control cells.   
RT-PCR analysis 
Total RNA was extracted from JAR cells using 
RNeasy mini kits (QIAGEN, Mississauga, Canada). 
Two micrograms of total RNA was reverse transcribed, 
and then PCR was performed using Ready-to-Go 
RT-PCR Beads (GE Healthcare Bio-Sciences, Piscata-
way, NJ, USA ), according to the manufacturer’s pro-
tocol in a TAKARA amplification cycler. The se-
quences of the human primers used were as follows: 
Bag-1: sense, 5’-GGA GGA TGA GTG ACG AGT TTG 
TG-3’, antisense, 5’-TGG TGG GAT CGG AAC TTG 
GG-3’. Bad: sense, 5’-GAG GAT GAG TGA CGA GTT 
TGT G-3’, antisense, 5’-TGG TGG GAT CGG AAC 
TTG GG-3’. JNK 1: sense, 5’-AGA ACC AAG AAT 
GGA GTT ATA CGG-3’, antisense, 5’-GTC TTC AAT 
GTC AAC AGA TCC GA-3’. Hsp-70: sense, 5’-GCC 
TTC TGC CGT GAT TGT GAG-3’, antisense, 5’-GGC 
AAG GTG GAG ATC ATC GC-3’. PTEN: sense, 
5'-CCA ATG TTC AGT GGC GGA ACT-3; antisense, 
5'-GAA CTT GTC TTC CCG TCG TGTG-3'. GAPDH: 
sense, 5’-CAT GGA GAA GGC TGG GGC TC-3’, an-
tisense, 5’-CAC TGA CAC GTT GGC AGT GG-3’. The 
conditions used for the PCR were as follows: 94°C for 
2 min, 30 cycles of 94°C for 45 sec, 68°C for 45 sec, and 
74°C for 1 min, with final extension at 74°C for 3 min. 
The integrity of the RNA used for RT-PCR was con-
firmed using GAPDH synthesis as a positive control 
reaction as described previously. The amplified 
RT-PCR products were analyzed electrophoretically 
through 2% agarose gels, visualized by ethidium bro-
mide staining, and photographed under UV illumina-
tion. 
Semiquantitative real-time RT-PCR 
Total RNA was extracted from JAR cells using 
RNeasy mini kits (QIAGEN, Valencia CA, USA). 
Real-time semiquantitative RT-PCR was performed 
using an ABI 7500 RealTime PCR System 
(Perkin-Elmer, Applied Biosystems, Foster City, CA, 
USA). Total RNA was reverse transcribed to cDNA, 
using a QuantiTect Reverse Transcription kit 
(QIAGEN, Valencia CA, USA), according to the 
manufacturer’s protocol. Briefly, template RNA, 
gDNA wipeout buffer, and RNase-free water were 
incubated at 42°C for 2 minutes. Then Quantiscript 
reverse transcriptase, quantiscript RT buffer, and a 
commercially available RT primer mix were added 
and incubated at 42°C for 15 minutes, followed by in-
cubation at 95°C for 3 minutes to inactivate Quantis-
cript reverse transcriptase. An aliquot of each finished 
reverse transcription reaction was added to the 
real-time PCR mix. A probe for GAPDH was used for 
normalization. The following quantification cycling 
protocol was used: 50°C for 2 minutes, followed by 
95°C for 15 minutes, and 45 cycles of 76°C for 30 sec-
onds, 94°C for 15 seconds, and 56°C for 35 seconds. 
JNK, PTEN, and caspase-3 mRNA quantities were 
analyzed in triplicate, normalized against GAPDH as 
a control gene and expressed in relation to a calibrator 
sample.  
Statistical analysis 
 Experiments for the detection of cell viability, 
those for the quantitation of internucleosomal DNA 
fragmentation, and JNK 1&2 were carried out in du-
plicate and repeated three times. Differences between 
the groups were evaluated with Mann-Whitney U-test. 
Experiments of the PowerBlot protein array were car-
ried out twice, and the real-time RT-PCR was carried 
out three times, and results were expressed as mean 
+/- SD.   
3.  Results 
Cellular uptake and distribution of Bag-1 Mor-
pho/AS.  
The cellular uptake and distribution of 
FITC-labeled Bag-1 Morpho/AS was examined using 
a fluorescent microscope. Fluorescence was mainly 
observed in cytosol areas in transfected cells. 
FITC-labeled Bag-1 Morpho/AS was transfected into 
almost all JAR cells by EPEI-mediated transfection 
(data not shown). Int. J. Med. Sci. 2007, 4 
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Hypoxia-induced apoptosis in the JAR cell line, and 
Bag-1 Morpho/AS enhanced apoptosis of the cell 
line. 
With hypoxic treatment for 24 hours, internu-
cleosomal DNA fragmentation increased in a 
time-dependent manner for JAR cells. In cells trans-
fected with Bag-1 Morpho/AS, significantly more in-
ternucleosomal DNA fragmentation was detected than 
in non-treated control JAR cells after hypoxia treat-
ment, also in a time-dependent 
manner (Fig. 1).   
Figure 1. Internucleosomal DNA 
fragmentation with hypoxia (-fold of 
control). Internucleosomal DNA 
fragmentation was measured with a 
Cell Death Detection ELISA after 12 
hours and 24 hours exposure to hy-
poxia. From the absorbance at 405nm, 
the percent fragmentation in compari-
son that in controls was calculated 
according to the formula: DNA frag-
mentation(-fold of control) = absorb-
ance of treated cells / absorbance of 
control cells. All points were done 
duplicate X three times, and the results 
are average +/- SD. “* “means p<0.05, 
and “n.s”: means statistically not sig-
nificant.  
 
 
Altered expression of apoptosis-related proteins by 
hypoxia in the JAR cell line demonstrated using the 
PowerBlot Western array. 
We used a proteomic method to identify hy-
poxia-regulated proteins. The PowerBlot is an anti-
body-based Western array that can rapidly analyze 
the expression levels of many proteins at once. We 
selected 40 apoptosis-related proteins and determined 
that 22 of those proteins were significantly increased 
or decreased after hypoxia treatment. A summary of 
the PowerBlot expression data of proteins detected is 
listed in Table 1. Briefly, Bcl-x-28kD, caspase-3, cas-
pase-7, Hsp70-64kD, PTEN, and JNK phos-
phor-specific showed 2.39-fold, 4.96-fold, 2.16-fold, 
1.85-fold, 1.92-fold, and 2.29-fold increases of protein 
expression, respectively. Bag-1-29kD was only ex-
pressed after hypoxia treatment. On the other hand, 
Bad, pan-JNK/SAPK1-50kD, pan-JNK/SAPK-1-43kD, 
Bcl-2, Bid-21kD, and caspase-8 showed 1.92-fold, 
2.21-fold, 2.17-fold, 1.91-fold, 9.40-fold, and 2.76-fold 
decreases of protein expression, respectively. 
Both decreases and increases in the expression of 
proapoptotic and antiapoptotic proteins were detected. 
PowerBlot analysis showed altered expression of 
many proteins involved in apoptosis, including the 
expression profiles of proteins involved in the mito-
chondrial (bcl-2, bax, and bcl-x, etc.) and stress reac-
tion-related pathways of apoptosis (Fig. 2). 
Table 1 Altered protein expression of JAR cells induced by hypoxia in the apoptosis pathways using PowerBlot. 
Protein Confidence 
level 
(-) Under 
(+)Over 
Fold 
change 
Protein Confidence 
level 
(-) Under 
(+)Over 
Fold 
change 
Bad 3  -  1.92  Bid  1  -  9.40 
Bcl-x 3  +  2.39  Caspase-6  1  +  0/+ 
Caspase-3 3  +  4.96  Caspase-8  1  -  2.76 
Caspase-7 3  +  2.16  Hsp90  1  -  2.32 
Hsp70-64kD 3  +  1.85  Bax  0    1.25 
Pan-JNK/SAPK1-50kD  3 -  2.21  FADD  0   1.15 
PTEN 3  +  1.92         
JNK-phospho-specific   2 +  2.29         
Pan-JNK/SAPK1-43kD  2 -  2.17         
BAG-1  1 +  0/+        
Bcl-2  1 -  1.91         
Fold change means a semiquantitative value that represents the general trend of protein changes for the experimental sample to control detected by 
using the Odyssey Infrared Imaging System. (+) means an increase of signal intensity, and (-) means a decrease of signal intensity after exposure to 
hypoxia. 
Confidence levels are defined as: Level 3 – Changes greater than 2 fold from good quality signals that also pass a visual inspection. Level 2 - 
Changes greater than 2 fold from good quality signals that do not pass a visual inspection. Level 1 – Changes greater than 2 fold from low 
quality signals. Level 0 – No significant protein changes. 
Fold changes: a semiquantitative value that represents the general trend of protein changes for experimental sample relative to control. 0/+ 
means no expression in control and the expression after treatment. Int. J. Med. Sci. 2007, 4 
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Figure 2 PowerBlot patterns of JAR cells. Forty elements of various apoptosis-related proteins were spotted onto the mem-
brane. A. Control( exposed to aerobic condition). B. Low O2( exposed to hypoxic condition for 24 hours). After the hypoxia 
treatment, cell extracts were analyzed with the PowerBlot western array. 40 apoptosis-related proteins described in Table 1 
were examined. The membrane was scanned at 700 nm using the Odyssey Infrared Imaging System. *a-f in the Figure are as 
follows; a:Bad, b:Bag-1, c:caspase-3, d:Hsp70, e:JNK/SAPK, f:PTEN. 
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Altered expression after hypoxia treatment in JAR 
cell line transfected with Bag-1 Morpho/AS of 
apoptosis-related proteins using PowerBlot West-
ern array. 
A summary of the PowerBlot-detected expres-
sion data of proteins is given in Table 2. Briefly, cas-
pase-3, GST-p, Hsp70-64kD, Bcl-x-22kD, PTEN, and 
caspase-7 showed 3.75-fold, 3.31-fold, 2.66-fold, 
2.32-fold, 1.91-fold, and 1.86-fold increases of protein 
expression, respectively. On the other hand, 
smac/DIABLO, Bag-1, and JNK phosphor-specific 
showed 3.55-fold, 3.53-fold, and 2.06-fold decreases of 
protein expression, respectively. Interestingly, Bad, 
pan-JNK/SAPK1-50kD, pan-JNK/SAPK-1-43kD, Bcl-2, 
and Bid-21kD did not show decreased protein levels 
after hypoxia treatment with the transfection of Bag-1 
Morpho/AS, although the expression of PTEN and 
Bcl-X was not changed. Thus Bag-1 showed inhibitory 
effects on the proapoptotic proteins Bid and Bad. 
Bag-1 also exhibited apoptotic effects, probably by 
inhibiting the expression of Bcl-2 and by modulating 
phosphorylation of JNK.   
Table 2 Altered protein expression of JAR cell with anti-Bag-1 antisense oligo nucleotide induced by hypoxia in the apop-
tosis pathways using PowerBlot. 
Protein Confidence 
level 
(-) Under 
(+) Over 
Fold 
change 
Protein Confidence 
level 
(-) Under 
(+)Over 
Fold 
change 
Bcl-x 3  +  2.32  Ki-67  1  +    0/+ 
Caspase-3 3  +  3.75  Bad  0   1.08 
Caspase-7 3  +  1.86 Bid  0   1.19 
GST-p 3  +  3.31  Apaf-1  0    1.23 
PTEN 3  +  1.91  Bcl-2  0    1.01 
Smac/DIABLO  3 -  3.55  Pan-JNK/SAPK1-43kD  0    1.07 
Hsp70-64kD 2  +  2.66  TRADD  0    1.22 
Caspase-6 1  +  0/+  Bag-1       No 
exp. 
JNK-phospho-specific  1 -  2.06        
Fold change means a semiquantitative value that represents the general trend of protein changes for the experimental sample to control detected by 
using the Odyssey Infrared Imaging System. (+) means an increase of signal intensity, and (-) means a decrease of signal intensity after exposure to 
hypoxia. 
Confidence levels are defined as: Level 3 – Changes greater than 2 fold from good quality signals that also pass a visual inspection. Level 2 - 
Changes greater than 2 fold from good quality signals that do not pass a visual inspection. Level 1 – Changes greater than 2 fold from low 
quality signals. Level 0 – No significant protein changes. 
Fold changes: a semiquantitative value that represents the general trend of protein changes for experimental sample relative to control. 0/+ 
means no expression in control and the expression after treatment.   
No exp. means no expression both in control and after treatment. 
Figure 3. Phosphorilated JNK1&2 
protein levels (-fold of control) of 
JAR over 24 hours of exposure to 
hypoxia. The phosphorylated JNK 
1&2 protein level was measured with 
Phospho-JNK1&2(pThr
183/pTyr
185) 
ELISA after 12 hours and 24 hours 
exposure to hypoxia. From the ab-
sorbance at 450nm, the phosphory-
lated JNK 1&2 protein level in com-
parison with the control was calcu-
lated according to the formula: 
Changes in the level of phosphory-
lated JNK 1&2 (-fold of control) = 
absorbance of treated cells / absorb-
ance of control cells. All points were 
done duplicate X three times, and the 
results are average +/- SD. “* “means 
p<0.05, and “n.s”: means statistically 
not significant.  
 
Changes in the level of phosphorylated JNK 1&2 
protein. 
We also quantitated changes in the protein level 
of phosphorylated JNK 1&2 over 24 hors for the cell 
line. According to the PowerBlot data, increased ex-
pression of phosphorylated JNKs in JAR cells was de-
tected after exposure to hypoxia. On the other hand, 
JAR cells transfected with Bag-1 Morpho/AS did not 
show such an increase in the expression of phos-
phorylated JNKs. As shown in Fig. 3, 12hr exposure to 
hypoxia caused almost no increase in the phosphory-
lated JNKs protein level in the cell line. 
Twenty-four-hour exposure to hypoxia resulted in a Int. J. Med. Sci. 2007, 4 
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marked increase (1.8-fold of control) in the level of 
phosphorylated JNK 1&2, whereas 24hr exposure to 
hypoxia resulted in a decrease (0.4-fold of the control) 
in the level of phosphorylated JNK 1&2 for JAR cells 
with Bag-1 Morpho/AS. 
Figure 4. Expression of 
three representative genes 
by Semiquantitative 
RT-PCR after 24 hours 
exposure to hypoxia. 
mRNA was obtained after 
24 hours exposure to hy-
poxia for JAR cells and 
JAR cells with Bag-1 
Morpho/AS. Real-time 
semiquantitative RT-PCR 
was performed using an 
ABI 7500 RealTime PCR 
System. JNK, PTEN, and 
caspase3 mRNA quanti-
ties were analyzed in trip-
licate, normalized against 
GAPDH as a control gene. 
The results are average +/- 
SD. “* “means p<0.05, 
and “n.s”: means statisti-
cally not significant. 
RT-PCR and real-time RT-PCR 
To confirm the changes observed using the Pow-
erBlot, we measured the expression of several repre-
sentative genes by RT-PCR and real-time RT-PCR. As 
shown in Tables 3, 4 and Fig.4, downregulation of 
three representative genes was detected after 24hr ex-
posure to hypoxia. On the other hand, the protein ex-
pression of caspase 3, PTEN, and JNK1 in JAR cells 
exhibited a 4.96-fold increase, 1.92-fold increase, and 
2.17-fold decrease, respectively. For JAR cells trans-
fected with Bag-1 Morpho/AS, they exhibited a 
3.75-fold increase, 1.91-fold increase, and 1.07-fold 
increase, respectively. Thus discrepancies between 
mRNA expression and the PowerBlot results were 
detected. Furthermore, as shown in Table 4, such ex-
pression discrepancies between mRNA and the pro-
tein were detected for several other genes. 
Table 3 Slope of standard curve and correlation coefficient of representative genes by Semiquantitative RT-PCR after 24 
hours exposure to hypoxia. 
Gene Slope  Correlation  coefficient 
JNK1 -3.24  0.989 
PTEN -3.59  0.993 
Caspase 3  -3.25  0.996 
GAPDH -3.53  0.999 
mRNA was obtained after 24 hours exposure to hypoxia for JAR cells and JAR cells with Bag-1 Morpho/AS. Real-time semiquantitative RT-PCR was 
performed using an ABI 7500 RealTime PCR System. Then standard curves were obtained, and the slope and correlation coefficient were calculated for 
each gene.  
Table 4 Comparison between mRNA and protein expression of representative genes and proteins after hypoxia treatment for 
24 hours. 
 JAR   JAR+Bag-1  Morpho/AS   
Name of gene  Protein expression  mRNA expression Protein  expression mRNA  expression 
JNK  ↑ +  ↓ + 
PTEN  ↑ +  ↑ + 
Caspase3  ↑ +  ↑ + 
Bag-1  ↑ +  -  - 
Hsp-70  ↑ -  ↑ - 
Bad  ↓ +  ↑ + 
Protein expression: ↑ means increased expression of protein. ↓ means decreased expression of protein. → means no changes of protein expression. - 
means negative expression 
mRNA expression: (+) means positive, and ( -) means negative expression by RT-PCR. 
4.  Discussion 
Apoptosis is a cascade of events that involves ac-
tivation of many genes and synthesis of numerous 
proteins. Upon exposure to hypoxia, an increase in 
internucleosomal DNA fragmentation as a result of 
apoptosis was noted in JAR cells. The internu-
cleosomal DNA fragmentation induced by hypoxia Int. J. Med. Sci. 2007, 4 
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was increased with the transfection of Bag-1 Mor-
pho/AS, which suggested that Bag-1 was related to 
the inhibition of apoptosis of trophoblastic cells under 
hypoxic conditions. By using the PowerBlot Western 
array technique, we detected global changes in the 
proteins related to apoptosis induced by hypoxia. 
There are two major intracellular apoptosis-signaling 
cascades; mitochondrial pathways and death receptor 
pathways [4]. Mitochondrial pathways are regulated 
by various proapototic and antiapoptotic proteins, 
which either induce or prevent the permeabilization of 
the outer mitochondrial membrane. The 
stress-activated pathway, which leads to activation of 
caspase 3 and/or caspase 9, is also thought to be in-
volved. On the other hand, death receptor pathways 
are regulated by signals from death receptors that ex-
ist on the cell surface membrane. Fas-induced apop-
tosis and/or the tumor necrosis factor (TNF)-related 
pathway, which lead to the activation of caspase 8, are 
thought to be involved in this pathway.   
Indeed, apoptosis is more prevalent in tro-
phoblasts from pregnancies complicated by pree-
clampsia and IUGR, compared with similar specimens 
obtained from uncomplicated pregnancies. And it is 
reported that the elevated apoptosis of trophoblasts 
observed in such complications might be due, in part, 
to placental oxidative stress, which can be triggered by 
hypoxia [12]. Thus hypoxia of trophoblasts can be a 
cause of preeclampsia and IUGR. The mechanism by 
which hypoxia mediates the proapoptotic effect is 
thought to involve the mitochondrial pathway. Levy 
et al. demonstrated that hypoxia enhanced apoptosis 
in term trophoblasts by decreasing the expression of 
Bcl-2 while increasing the expression of p53 and Bax 
and activating caspases [13]. In addition, DiFederico et 
al. reported that the apoptotic extravillous cytotro-
phoblasts detected in preeclamptic samples were 
negative for Bcl-2 expression, suggesting that a de-
crease in Bcl-2 expression might induce apoptosis in 
extravillous trophoblast cells [14]. However, most of 
those reports only looked at certain apoptotic path-
ways. 
 In this study, we have elucidated the impor-
tance of several hypoxia-induced apoptosis pathways 
using a PowerBlot Western array. Increased expres-
sion of proapoptotic proteins, such as caspase-3, cas-
pase-7, PTEN, and JNK phosphor-specific-54-kD, and 
decreased expression of antiapoptotic protein Bcl-2, 
which would contribute to the induction of apoptosis, 
were detected. Furthermore, increased expression of 
antiapoptotic proteins such as Bag-1, Hsp70, and Bcl-X, 
and decreased expression of proapoptotic proteins 
such as Bid and Bad, which both would contribute to 
the prevention of apoptosis, were also detected. 
However, the contribution of death receptor pathways 
seemed to be low for the hypoxia-induced apoptosis 
in this study, although several reports have demon-
strated the importance of Fas and FasL [15], and that 
of TNF-R1 and TNF-α[16], in preeclampsia. 
Thus, hypoxia-induced changes in the expression 
of both proapoptotic and antiapoptotic proteins, and 
the balance of the expression of such positive and 
negative regulators of apoptosis would determine 
apoptotic propensity. In this study, we focused on the 
role of Bag-1 in the regulation of trophoblastic cells to 
induce apoptosis under hypoxia. Growth of tro-
phoblast tissue in early pregnancy is rapid and ac-
complished in an unusually hypoxic environment. 
However, apoptosis is considered to be suppressed 
even under those hypoxic conditions. As we men-
tioned above, antiapoptotic Bcl-2 is reported to be 
overexpressed in cytotrophoblasts, and a decrease in 
the expression of Bcl-2 and increase of apoptotic cells 
are seen in preeclampsia. Thus antiapoptotic proteins 
can play an important role in preventing apoptosis of 
trophoblasts, which leads to various hypoxia-induced 
obstetrics complications. In this study, we detected an 
increase in the expression of another antiapoptotic 
protein, Bag-1, although the expression of Bcl-2 pro-
tein was decreased.   
Bag-1 is a multifunctional protein containing a 
domain that binds tightly to heat shock 70-kD (Hsp70) 
family molecular chaperones and appears to modulate 
stress responses [17]. It is reported to be associated 
with enhanced cell proliferation and survival, and 
eventually suppresses apoptosis [18].   
In this study, internucleosomal DNA fragmenta-
tion induced by hypoxia was increased with the 
transfection of Bag-1 Morpho/AS, which also affected 
the expression of Bid, Bad, Bcl-2, JNK, and phos-
phorylated JNK, although the expression of PTEN and 
Bcl-X was not changed. PTEN (phosphatase and 
tensin homolog deleted on chromosome 10) is a tumor 
suppressor gene that regulates cell growth, apoptosis, 
and proliferation. PTEN is known to negatively regu-
late Akt activation by preventing its phosphorylation 
[19]. Overexpression or enhanced activation of PTEN 
induces apoptosis by blocking Akt activation, leading 
to increased Bad and caspase-9 activities. In this study, 
increased expression of PTEN was detected after the 
exposure to hypoxia. However, transfection of Bag-1 
Morpho/AS to JAR cells did not alter the expression 
of PTEN after the exposure to hypoxia, which would 
mean that the expression of PTEN, and also that of 
Bcl-X, was independent of Bag-1. Real-time PCR 
showed decreased expression of PTEN after 24hr ex-
posure to hypoxia, and transfection of Bag-1 Mor-
pho/AS into JAR cells also resulted in a decrease of 
PTEN expression after the exposure to hypoxia. The 
time lag between protein synthesis and gene expres-
sion, and posttranslational modification of proteins 
might be a cause of this discrepancy. Stress-activated 
hypoxia-induced pathways were also shown to be 
important. The PowerBlot showed increased expres-
sion of phosphorylated c-Jun N-terminal 
kinase/stress-activated protein kinase (JNK/SAPK) 
(activated type), and decreased expression of non-
phosphorylated JNK/SAPK (inactivated type) after 
exposure to hypoxia, although the mRNA expression 
was decreased after exposure to hypoxia for both 
transfected cells and control cells. Interestingly, the 
phosphorylation of JNK/SAPK was inhibited by the Int. J. Med. Sci. 2007, 4 
 
44
transfection of Bag-1 Morpho/AS. This phenomenon 
was also confirmed by quantitive ELISA of phos-
phorylated JNKs. JNKs are known to activate down-
stream caspases such as caspase-3 and -6. Our study 
indicates that Bag-1 might control apoptosis not by 
regulation of the JNK gene, but by modulating phos-
phorylation of JNKs. Thus, Bag-1 may inhibit apop-
tosis by suppressing the expression of Bid and Bad. 
Bag-1 may also enhance apoptosis by inhibiting the 
expression of Bcl-2 and by modulating phosphoryla-
tion of JNK.   
In conclusion, various pro- and antiapop-
tosis-related proteins were expressed in the process of 
hypoxia-induced apoptosis in the trophoblastic cell 
line JAR. Mitochondrial pathway-related and stress 
reaction-induced pathways, as well as PTEN, were 
r e v e a l e d  t o  b e  i m p o r t a n t  i n  t h i s  s t u d y .  I t  w a s  a l s o  
demonstrated that antiapoptotic Bag-1 controlled the 
expression and function of several apoptosis-related 
proteins. Therefore, in placentas with hypoxia, Bag-1 
might play an important role in the development of 
hypoxia-related diseases such as preeclampsia.   
How can we clinically apply these results? 
Changes of the expression of various hypoxia-related 
proteins originated from trophoblastic cells in the 
clinical samples such as serum or amnionic fluid, 
might reflect the degree of hypoxic damages of pla-
centa. We are looking at changes of various hypoxia 
and apoptosis-related proteins detected in this study 
in clinical samples during pregnancy. We believe that 
some of those proteins can be a target for the early 
detection of preeclampsia and IUGR.   
Furthermore, we have also demonstrated that the 
PowerBlot Western array represents a powerful ap-
proach to identify key molecules in the course of hy-
poxia-induced apoptotic pathways. Such analysis of 
trophoblastic cells will, in the near future, yield in-
sights into the mechanisms of preeclampsia and other 
hypoxia-related obstetrical diseases and lead to the 
rational design of more effective strategies to detect 
hypoxic stress of the placenta and to establish “tai-
lor-made” approaches for patients with such diseases. 
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